# FDA Inspection 1318348 - Blood Assurance inc - May 21, 2026

Source: https://www.keypedia.com/records/fda_inspections/blood-assurance-inc/226b8120-f55b-49eb-abed-d88fa391eb50
Source feed: FDA_Inspections

> FDA Inspection 1318348 for Blood Assurance inc on May 21, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1318348
- Company Name: Blood Assurance inc
- Inspection Date: 2026-05-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1167480 - 2022-04-14](https://www.keypedia.com/records/fda_inspections/blood-assurance-inc/16ab2d4b-2938-484c-aed8-f4d6a153b2e5)
- [FDA Inspection 1167480 - 2022-04-14](https://www.keypedia.com/records/fda_inspections/blood-assurance-inc/aee7d976-36f1-48e8-918f-aa98f26440ba)

Company: https://www.keypedia.com/companies/blood-assurance-inc/969b7746-8f38-4aca-aef2-dd3841381c3f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d